Chamber and committees

To date, the Scottish Government has provided more than £2 billion to NHS Boards and Integration Authorities, with NHS Western Isles receiving £7.7 million, to address pressures arising from Covid-19.

We will continue to assess the impact of Covid-19, and its financial implications for our health service, in order to ensure that frontline services receive the support that they need throughout the pandemic.

The following table presents the information requested.

Table 1 : Number of readmissions with a diagnosis of deep-vein thrombosis readmitted within 90 days of discharge following an orthopaedic or any type of surgery.

In Scotland, it is estimated that over 9 in 10 adults, or 93.6% of the adult community population (95% credible interval: 92.3% to 94.7%) would have tested positive for antibodies to SARS-CoV-2 from a blood sample in the week beginning 9 August 2021, suggesting that they had the infection in the past or have been vaccinated. Those who have tested positive for antibodies may have obtained them from prior infection before vaccination.

Antibody data from the ONS COVID-19 infection survey was published by the Scottish Government on 1 September 2021 at: Coronavirus (COVID-19): ONS Infection Survey – antibody data – 1 September 2021 - gov.scot (www.gov.scot).

The UK-wide Principle Trial (Platform Randomised Trial of Treatments on the Community for Epidemic and Pandemic Illness) funded by the National Institute for Health Research (NIHR) is looking at early treatment for COVID-19 to prevent ill health and hospitalisation. It is evaluating a number of potential treatments. More information about this trial is at: Join the PRINCIPLE Trial — PRINCIPLE Trial

The Scottish Government Chief Scientist Office is also funding a trial of a potential anti-viral medicine as an early treatment of COVID-19. More information about this trial is at: GETAFIX - Glasgow Early Treatment Arm FavipiravirX (getafix-trial.org.uk)

The following table shows the number of people who attended an abdominal aortic aneurysm screening appointment between January 2019 and July 2021. The programme was paused between 30 March 2020 and 6 July 2020 and when screening resumed it prioritised higher-risk screening participants.

It is important to note that the data below is management information and has not been subject to the necessary quality checks carried out for an official publication.

The following table shows the number of people screened for diabetic retinopathy in each month between January 2019 and July 2021. The Diabetic Eye Screening (DES) programme was paused between 30 March 2020 and 6 July 2020. When screening resumed, those at high risk of developing diabetic retinopathy were prioritised and invited first.

It is important to note that the following data is management information and has not been subject to the necessary quality checks carried out for an official publication.

Advice from clinicians is to continue to use PCR testing for international travel, which is more accurate than other forms of testing. In addition, positive results should be genomically sequenced, which is harder to do using other types of test. We will, however, consider the use of lateral flow testing as technology improves and more data is available. Regardless of any testing regime, individuals should be following the protocols set out to minimise transmission.

The regulation of nuisance calls and texts is reserved to the UK Government, the Scottish Government is committed to doing all it can to tackle this issue – and the scams that can underpin them – using our devolved powers.

Many of the proposed actions from the Nuisance Call Commission 2017 have been progressed and delivered. However, we recognise that further work needs to be done. That is why on 19 March 2021 we published Scotland’s Scams Prevention, Awareness & Enforcement Strategy 2021-24.

The strategy introduces a new framework for tackling scams, with an emphasis on: disrupting scams at source; building capacity, skills and resilience amongst individuals to avoid the risk that scams pose; streamlining the reporting and advice landscape so that people can access the right support at the right time to meet their needs; and improving coordination and intelligence sharing between frontline advice providers, enforcement bodies and wider advocacy organisations.

A key part of this work is supporting technological innovation. Since 2017, we have been providing funding to Trading Standards Scotland for the purchase and roll out of domestic call blocker devices to the homes of individuals in some of the most vulnerable circumstances in Scotland. A recent report on the effectiveness of these call blockers by Trading Standards Scotland indicated that the devices have blocked 779,633 calls and an estimated 1,265 scams have been prevented.

A new Strategic Partnership was established on 12 August to oversee delivery of the strategy, including development of a robust monitoring framework to assess impacts over time. A progress update report will be produced by the end of 2022-23.

A public consultation on the draft Framework for Chronic Pain Service Delivery is expected to begin this Autumn. We are grateful for the input provided to date by people with lived experience, clinical, third-sector and other stakeholders in helping us to shape this draft and welcome further feedback as part of the public consultation in order to help us improve services and support for people with chronic pain in Scotland.

The COVID pandemic has inevitably affected A&E attendance and the pressure is being felt across the UK. Our NHS staff have faced unprecedented pressures over recent weeks as they work tirelessly and consistently to respond to the pandemic whilst continuing to provide vital treatment and optimal patient care. We are in daily contact with every Board, including NHS Forth Valley, and are monitoring the situation closely.

The significant pressures currently presenting in Health Boards, including NHS Forth Valley, are primarily as a result of reduced capacity due to infection control, staffing pressures as a result of self-isolation and annual leave, and an increase in attendances to A&E by those who are much sicker and require higher levels of care.

In July, NHS Forth Valley received their share of the additional £12 million in funding for Boards to support non-COVID emergency care by increasing staffing resource, recruitment is underway.

We are in daily contact with NHS Forth Valley and continue to support improvement work with the Board and the Health & Social Care Partnerships to minimise delays for patients no matter where they are in the system.